BioTuesdays

Tag - AC5 Topical Hemostatic Device

Arch moving to regulatory stage this year

By Len Zehr Arch Therapeutics (OTCQB:ARTH) has multiple regulatory filings planned in the U.S. and Europe this year for its AC5 Topical Hemostatic Device as the biopharma company shifts to regulatory-stage footing ahead...